Victoria Argentova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Victoria Argentova has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
D. A. Dolgikh
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya ul. 16/10, GSP-7, Moscow, Russia
6 shared publications- Mikhail P. Kirpichnikov
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia
5 shared publications T. K. Aliev
Department of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State University, Moscow, Russia
5 shared publicationsV. A. Toporova
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya ul. 16/10, GSP-7, Moscow, Russia
5 shared publications- Teimur Aliev
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
4 shared publications P. G. Sveshnikov
Russian Research Center for Molecular Diagnostics and Therapy
3 shared publications
Latest Publications
- Open Access
- 4 October 2026
- Published by Elsevier in Clinical Immunology
- Vol. 288
Development of bi-functional hybrid IgGA antibodies for enhancing cancer immunotherapy
- 4 October 2026
- Published by Elsevier in Clinical Immunology
- Vol. 288
Open AccessDevelopment of bi-functional hybrid IgGA antibodies for enhancing cancer immunotherapy
- Open Access
- 18 October 2025
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 23 (4) , 100588
Influence of growth factors and different supplements on metabolic response and productivity of IgA-producing CHO cell lines
- 18 October 2025
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 23 (4) , 100588
Open AccessInfluence of growth factors and different supplements on metabolic response and productivity of IgA-producing CHO cell lines
- Open Access
- 22 February 2023
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 21 (1) , 1-10
Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
- 22 February 2023
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 21 (1) , 1-10
Open AccessOptimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
- 4 April 2022
- Published by Taylor & Francis in Biotechnology and Genetic Engineering Reviews
- Vol. 38 (2) , 247-269
Features, modulation and analysis of glycosylation patterns of therapeutic recombinant immunoglobulin A
Increasing the production of recombinant antibodies while ensuring high and stable protein quality remains a challenge in mammalian cell culture. This review is devoted to advances in the field of obtaining stable and optimal glycosylation of therapeutic antibodies based on IgA, as well as the subsequent issues of glycosylation control of glycoproteins during their production. Current studies also demonstrate a general need for a more fundamental understanding of the use of CHO cell-based producer cell lines, through which the glycoprofile of therapeutic IgA antibodies is produced and the dependence of glycosylation on culture conditions could be controlled. Optimization of glycosylation improves the therapeutic efficacy and can expand the possibilities for the creation of highly effective glycoprotein therapeutic drugs. Current status and trends in glycan analysis of therapeutic IgA, dominantly based on mass spectrometry and lectin microarrays are herein summarised as well.
- 4 April 2022
- Published by Taylor & Francis in Biotechnology and Genetic Engineering Reviews
- Vol. 38 (2) , 247-269
Features, modulation and analysis of glycosylation patterns of therapeutic recombinant immunoglobulin A
Increasing the production of recombinant antibodies while ensuring high and stable protein quality remains a challenge in mammalian cell culture. This review is devoted to advances in the field of obtaining stable and optimal glycosylation of therapeutic antibodies based on IgA, as well as the subsequent issues of glycosylation control of glycoproteins during their production. Current studies also demonstrate a general need for a more fundamental understanding of the use of CHO cell-based producer cell lines, through which the glycoprofile of therapeutic IgA antibodies is produced and the dependence of glycosylation on culture conditions could be controlled. Optimization of glycosylation improves the therapeutic efficacy and can expand the possibilities for the creation of highly effective glycoprotein therapeutic drugs. Current status and trends in glycan analysis of therapeutic IgA, dominantly based on mass spectrometry and lectin microarrays are herein summarised as well.
- Open Access
- 13 January 2022
- Published by Elsevier in JID Innovations
- Vol. 2 (2) , 100096
Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal Antibody
- 13 January 2022
- Published by Elsevier in JID Innovations
- Vol. 2 (2) , 100096
Open AccessDetrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal Antibody
- 1 December 2020
- Published by Pleiades Publishing Ltd in Applied Biochemistry and Microbiology
- Vol. 56 (9) , 902-908
Effects of Fibroblast Growth Factor-2 and Other Microsupplements on the Productivity of IgG- and IgA-Producing Cell Lines
Several serum-free media have been developed and are successfully used at present for the cultivation of various recombinant eukaryotic cell lines. Therapeutic recombinant IgA antibodies have recently been increasingly used along with numerous IgG1 isotype antibodies. Therefore, it became necessary to improve the growth characteristics, metabolism, and productivity of cell cultures producing these antibodies. The stimulating effect of a complex supplement containing Zn salts and FGF-2 on cell cultivation on basal media, DMEM and IMDM, was revealed in this work. The addition of dextran sulfate sodium salt and iron citrate to the basal medium was accompanied by improved productivity of stable IgG- and IgA-producing cell lines, as well as the homogeneity and density of cell cultures, which is most important in IgA-antibody production.
- 1 December 2020
- Published by Pleiades Publishing Ltd in Applied Biochemistry and Microbiology
- Vol. 56 (9) , 902-908
Effects of Fibroblast Growth Factor-2 and Other Microsupplements on the Productivity of IgG- and IgA-Producing Cell Lines
Several serum-free media have been developed and are successfully used at present for the cultivation of various recombinant eukaryotic cell lines. Therapeutic recombinant IgA antibodies have recently been increasingly used along with numerous IgG1 isotype antibodies. Therefore, it became necessary to improve the growth characteristics, metabolism, and productivity of cell cultures producing these antibodies. The stimulating effect of a complex supplement containing Zn salts and FGF-2 on cell cultivation on basal media, DMEM and IMDM, was revealed in this work. The addition of dextran sulfate sodium salt and iron citrate to the basal medium was accompanied by improved productivity of stable IgG- and IgA-producing cell lines, as well as the homogeneity and density of cell cultures, which is most important in IgA-antibody production.
- 7 September 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 21 (10) , 990-996
Effects of Succinic Acid Supplementation on Stable Cell Line Growth, Aggregation, and IgG and IgA Production
Background: Immunoglobulin (Ig) G is the most commonly used therapeutic antibodies. Recently, the interest in IgA antibodies to treat respiratory infectious diseases has been increasing. The reason for the inefficient use of IgA is recombinant antibody aggregation in cell culture, affecting the longevity and productivity of cell lines. Lactate is an important metabolite that affects the cultivation of stable cell lines producing monoclonal antibodies. Methods: In the present study, we investigated whether different combinations of succinic acid and micro-additives affect lactate production, which correlates with productivity. The effect of succinic acid substitution on productivity of cells producing IgG/IgA was analyzed using the static culture method in a six-well plate. Lactate was measured in supernatant of cell culture indirectly by using the activity of Lactate Dehydrogenase (LDH).A low lactate level was observed in cultivation medium supplemented with succinic acid or asparagine combined with some inorganic salts. Result: The results also demonstrated the effect of component supplementation on homogeneity, longevity, and productivity of cell culture. Supplementation of succinic acid eliminated cell aggregation and improved homogeneity of stable cell lines producing IgG and, especially, IgA. Conclusion: Overall, succinic acid supplementation to the culture medium has potential biotechnological applications in the production IgG and IgA.
- 7 September 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 21 (10) , 990-996
Effects of Succinic Acid Supplementation on Stable Cell Line Growth, Aggregation, and IgG and IgA Production
Background: Immunoglobulin (Ig) G is the most commonly used therapeutic antibodies. Recently, the interest in IgA antibodies to treat respiratory infectious diseases has been increasing. The reason for the inefficient use of IgA is recombinant antibody aggregation in cell culture, affecting the longevity and productivity of cell lines. Lactate is an important metabolite that affects the cultivation of stable cell lines producing monoclonal antibodies. Methods: In the present study, we investigated whether different combinations of succinic acid and micro-additives affect lactate production, which correlates with productivity. The effect of succinic acid substitution on productivity of cells producing IgG/IgA was analyzed using the static culture method in a six-well plate. Lactate was measured in supernatant of cell culture indirectly by using the activity of Lactate Dehydrogenase (LDH).A low lactate level was observed in cultivation medium supplemented with succinic acid or asparagine combined with some inorganic salts. Result: The results also demonstrated the effect of component supplementation on homogeneity, longevity, and productivity of cell culture. Supplementation of succinic acid eliminated cell aggregation and improved homogeneity of stable cell lines producing IgG and, especially, IgA. Conclusion: Overall, succinic acid supplementation to the culture medium has potential biotechnological applications in the production IgG and IgA.
- 1 May 2020
- Published by Elsevier in Journal of Biotechnology
- Vol. 314-315, 34-40
Influence of media composition on recombinant monoclonal IgA1 glycosylation analysed by lectin-based protein microarray and MALDI-MS
- 1 May 2020
- Published by Elsevier in Journal of Biotechnology
- Vol. 314-315, 34-40
Influence of media composition on recombinant monoclonal IgA1 glycosylation analysed by lectin-based protein microarray and MALDI-MS
- Open Access
- 1 September 2018
- Published by Pleiades Publishing Ltd in Molecular Biology
- Vol. 52 (5) , 786
Erratum to: “In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus” [Molecular Biology51, 804 (2017)]
- 1 September 2018
- Published by Pleiades Publishing Ltd in Molecular Biology
- Vol. 52 (5) , 786
Open AccessErratum to: “In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus” [Molecular Biology51, 804 (2017)]
- 1 January 2018
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 478 (1) , 34-36
The Development and Inmmunochemical Properties of the Dimer of Immunoglobulin A Specific to the Influenza Virus A Hemagglutinin
We obtained dimeric forms of IgA1- and IgA2m1-isotypes of FI6 antibody broadly specific to hemagglutinins of different subtypes of influenza A virus. It was shown that the dimers of IgA1 isotype are...
- 1 January 2018
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 478 (1) , 34-36
The Development and Inmmunochemical Properties of the Dimer of Immunoglobulin A Specific to the Influenza Virus A Hemagglutinin
We obtained dimeric forms of IgA1- and IgA2m1-isotypes of FI6 antibody broadly specific to hemagglutinins of different subtypes of influenza A virus. It was shown that the dimers of IgA1 isotype are...